Homologous human milk supplement for very low birth weight preterm infant feeding  by de Souza Grance, Thayana Regina et al.
REVISTA PAULISTA 
DE PEDIATRIA
Rev Paul Pediatr. 2015;33(1):28–33
1984-1462/© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights reserved.
www.rpped.com.br
DOI of refers to article: http://dx.doi.org/10.1016/j.rpped.2014.07.001
ORIGINAL ARTICLE
Homologous human milk supplement for very low birth  
weight preterm infant feeding
Thayana Regina de Souza Grance*, Paula de Oliveira Serafin,  
Débora Marchetti Chaves Thomaz, Durval Batista Palhares
Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil
Received 17 February 2014; accepted 4 July 2014
KEYWORDS
Very low-birth weight 
infant; 
Food supplements; 
Human milk
Abstract
Objective: To develop a homologous human milk supplement for very low-birth weight 
infant feeding, using an original and simplified methodology, to know the nutritional 
composition of human milk fortified with this supplement and to evaluate its suitability 
for feeding these infants.
Methods: For the production and analysis of human milk with the homologous additive, 
25 human milk samples of 45mL underwent a lactose removal process, lyophilization and 
then were diluted in 50mL of human milk. Measurements of lactose, proteins, lipids, 
energy, sodium, potassium, calcium, phosphorus and osmolality were performed.
Results: The composition of the supplemented milk was: lactose 9.22±1.00g/dL; pro-
teins 2.20±0.36g/dL; lipids 2.91±0.57g/dL; calories 71.93±8.69kcal/dL; osmolality 
389.6±32.4mOsmol/kgH2O; sodium 2.04±0.45mEq/dL; potassium 1.42±0.15mEq/dL; cal-
cium 43.44±2.98mg/dL; and phosphorus 23.69±1.24mg/dL.
Conclusions: According to the nutritional contents analyzed, except for calcium and 
phosphorus, human milk with the proposed supplement can meet the nutritional needs 
of the very low-birth weight preterm infant.
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
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Aditivo homólogo para a alimentação do recém-nascido pré-termo de muito baixo 
peso
Resumo
Objetivo: Elaborar um aditivo homólogo do leite humano para a alimentação do recém-
nascido de muito baixo peso com metodologia original e simplificada, conhecer a com-
posição nutricional do leite humano fortificado com esse aditivo e avaliar sua adequação 
para a alimentação desses recém-nascidos.
Métodos: Para a produção e análise do leite humano com o aditivo homologo, 25 amos-
tras de 45mL de leite humano passaram por processos de retirada de lactose, liofilização 
e foram diluídas em 50mL de leite humano. Foram feitas dosagens de lactose, proteínas, 
lipídios, energia, sódio, potássio, cálcio, fósforo e osmolalidade. 
Resultados: A composição do leite aditivado foi lactose 9,22±1,00g/dL; proteínas 
2,20±0,36g/dL; lípides 2,91±0,57g/dL; calorias 71,93±8,69kcal/dL; osmolalidade 
389,6±32,4mOsmol/kgH2O; sódio 2,04±0,45mEq/dL; potássio 1,42±0,15mEq/dL; cálcio 
43,44±2,98mg/dL; e fósforo 23,69±1,24mg/dL.
Conclusões: De acordo com os teores nutricionais analisados, com exceção do cálcio e do 
fósforo, o leite humano com o aditivo proposto pode atender as necessidades nutricionais 
do recém-nascido pré-termo de muito baixo peso.
© 2015 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos os 
direitos reservados.
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Introduction
Although it does not fully meet the nutritional needs of 
very low birth weight (VLBW) infants, human milk is rec-
ommended considering the digestive, metabolic and immu-
nological immaturity of these children.1,2 The American 
Academy of Pediatrics, as well as the Brazilian Ministry of 
Health3,4 recognize that human milk is beneficial and has 
many advantages for preterm infant feeding. However, due 
to its physiological characteristics, human milk supple-
mentation is recommended for these newborns.5-8
Considering its greater availability, cow’s milk protein is 
the most commonly used human milk supplement. The con-
cern with the short-term prognosis and the knowledge that 
nutrition in childhood is related to diseases of adulthood 
justify the study of supplement use that offers more ade-
quate quality amino acids and fatty acids, such as those 
derived from human milk itself.9-14
These studies show that it is possible to offer higher con-
centrations of human milk nutrients to VLBW infants with 
good gastrointestinal and metabolic tolerance. Among such 
studies, we highlight those using viable methodologies to be 
applied in human milk banks, such as evaporation and 
freeze drying of skim or non-skim human milk after removal 
of part of the lactose.9-14 In these studies, human milk was 
concentrated in a rotary evaporator, a procedure that 
requires the milk to be on average 30 minutes at a tempera-
ture higher than room temperature, which in addition to 
requiring extensive manipulation of the milk, allows greater 
protein denaturation due to time and temperature range.
By analyzing the techniques used in these studies, it was 
intended to develop a homologous human milk supplement 
for VLBW infant feeding with an original, simplified meth-
odology, which minimized the steps of handling and tem-
perature change such as heating, freezing and thawing 
during its production. We also sought to assess the nutri-
tional composition of human milk fortified with this supple-
ment and evaluate its suitability for the feeding of these 
newborns. 
Method
After approval by the Human Research Ethics Committee at 
Universidade Federal de Mato Grosso do Sul (UFMS) (n. 1975 
CAAE 0035.0.049.000-11), the homologous supplement of 
human milk was prepared.
The human milk used in the production and dilution of 
the supplement and the one used for comparison with the 
supplemented milk was expressed manually at home or in 
the human milk bank at the University Hospital of UFMS, 
being donated by volunteer mothers whose children were 
born at full-term, with a lactation period between 0 and 12 
months. Milk samples that were submitted to the selection 
criteria of the human milk bank and that showed an index 
≤2 in the acidity titration analysis (Dornic acidity) were used 
for supplement production.15 Milk samples used in the study 
were not selected according to lactation period, beginning 
or end of feeding, or time of day when the sample was col-
lected. Although all these characteristics influence the 
composition of human milk, it is known that human milk 
banks usually have no surplus milk supply, and therefore this 
study did not aim to work with selected milk samples.
The human milk samples underwent two phases of prepa-
ration: removal of lactose and lyophilization, as described 
below. First, 25 samples of human milk with 45mL were 
placed in conical plastic tubes, refrigerated at –22 °C for 24 
hours. After this period, the samples were submitted to cen-
trifugation at 3,500 rpm for 60 minutes in a NT 815 
(NOVATECNICA®, SP, Brazil) centrifuge at a temperature of 
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0-2 °C to allow the formation of lactose precipitate. The 
initial volume of 45mL was defined as it is the standard vol-
ume of the conical plastic tubes used in centrifuges. The 
samples were then heated in a water bath at 40 °C for the 
minimum time required for thawing to facilitate the stan-
dardized removal of 40mL of supernatant. The supernatant 
was then transferred to a glass container, using a graded 
pipette. The lactose deposit was discarded. The remaining 
contents of the lactose removal process were frozen again at 
–22 °C for 24 hours and placed in the vacuum chamber of the 
benchtop lyophilizer L101 (LIOBRAS®, SP, Brazil) for 72 hours. 
The lyophilization process results in milk dehydration by sub-
limation. The weight of each lyophilized sample varied 
according to the initial fat content, as the volume of fat does 
not change in lyophilization. Each lyophilized sample was 
diluted in 50mL of human milk. By diluting the supplement 
in 50mL of human milk, the goal was to have approximately 
a two-fold higher content of nutrients in the supplemented 
milk, as the supplement originated from 45mL. 
These samples were analyzed for the contents of lactose, 
protein, lipids, osmolality, sodium, potassium, calcium and 
phosphorous. The macronutrient measurement was per-
formed in Nexgen equipment (Bentley®, MN, USA), osmolali-
ty was evaluated in a VAPRO osmometer (WESCOR®, UT, 
USA), sodium and potassium measurement was performed in 
a B262 flame photometer (Micronal®, SP, Brazil), and calcium 
and phosphorus were measured in a spectrophotometer, with 
sample ash solution, according to the methodology described 
by Instituto Adolfo Lutz.16 For the comparison with the 25 
supplemented milk samples, macronutrients were measured 
in 20 samples of human milk without supplement. The min-
eral contents were compared with those reported by Palhares 
et al in 1987.17 The energy value of the samples was calcu-
lated in calories by multiplying each gram of carbohydrate 
and protein by 4, and each gram of fat by 9. 
During the supplement production, there was a concern 
regarding the maintenance of physicochemical quality and 
the lowest degree of microbiological contamination of the 
milk, as it may change the physicochemical aspects of milk. 
For that purpose, the following measures were taken: the 
containers that stored the milk during the two phases of 
preparation, as well as the volumetric pipette, were auto-
claved; milk fractionation for supplement preparation and 
dilution was carried out after disinfecting hands, using 
gloves, masks, aprons and caps; the rim of the flasks were 
sterilized using the Bunsen burner after being opened and 
before being closed; the water bath used in sample thawing 
was previously cleaned and the water replaced for each 
preparation; the lyophilizer vacuum capsule was cleaned 
before and after use; the lyophilized supplement was 
stored with the cap on, under freezing conditions, in the 
same container in which it was lyophilized, until it was 
diluted. In this study, the VLBW infants were not fed with 
the supplemented milk, and therefore the supplemented 
milk did not undergo microbiological analysis. However, the 
supplement was designed to be added to raw human milk, 
which should be pasteurized after being supplemented and 
submitted to routine microbiological analysis of the human 
milk bank before being offered to newborns. 
In experimental studies, compared groups should have a 
sample size that is sufficient to identify the difference 
between them, i.e., the sample size is related to the 
expected variation between the assessed groups, in addi-
tion to the confidence interval.18 Thus, the sample size in 
this study was defined by taking into account research in 
the area and the expected difference between the ana-
lyzed groups. To compare the nutritional content of supple-
mented human milk with human milk without supplement, 
the nonparametric Wilcoxon test was used in the GraphPad 
Software 2013, (GraphPad Software, Inc©, CA, USA). The 
significance level was set at 5%.
Results
The mean, standard deviation, minimum and maximum val-
ues of lactose, proteins, lipids, energy, osmolality, sodium, 
potassium, calcium and phosphorus of human milk with 
homologous supplement are shown in Table 1. Table 2 shows 
the mean concentrations of the nutritional content in 
human milk with homologous supplement compared to 
human milk without supplement. 
Discussion
Human milk supplementation emerged with the aim of adapt-
ing it to the nutritional needs of the very low (VLBW) and 
Table 1 Values  of lactose, proteins, lipids, energy, osmolality, sodium, potassium, calcium and phosphorus in the homologous 
supplemented human milk.
Nutrient Mean SD Minimum Maximum
Lactose (g/dL) 9.22 1.00 7.80 11.02
Protein (g/dL) 2.20 0.36 1.60 2.90
Lipids (g/dL) 2.91 0.57 1.81 4.01
Energy (kcal/dL) 71.93 8.69 54.88 89.45
Osmolality (mOsm/KgH2O) 389.6 32.4 335.00 438.00
Sodium (mEq/dL) 2.04 0.45 1.30 2.60
Potassium (mEq/dL) 1.42 0.15 1.22 1.66
Calcium (mEq/dL) 43.44 2.98 38.07 48.21
Phosphorus (mEq/dL) 23.69 1.24 21.72 25.51
SD, standard deviation.
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extremely low birth weight (ELBW) preterm infants. The use 
of commercial fortifiers and lactoengeneering techniques of 
human milk, among them the adequate structuring of human 
milk banks, the breakdown of fat globules of human milk by 
ultrasound and the concentration of human milk through 
evaporation of milk stored in these banks, renewed the enthu-
siasm for the use of human milk to feed these children.19
The technique described in this study was designed to 
minimize the manipulation steps, changes in temperature 
and the physical state of milk to attain better nutrient con-
servation. The handling of milk is only performed in the 
steps of storing it in conical plastic tubes and removal of 
the supernatant. As for the temperature changes, before 
the supplement production process, it is frozen and thawed 
only once during the process (at the supernatant removal 
after lactose precipitation), when it is again frozen, freeze-
dried at a temperature of –40 °C and maintained under 
freezing to be reconstituted in human milk. That is differ-
ent from the techniques described in similar studies.11-14
Nutrient concentration in human milk and the use of sup-
plements lead to increased osmolality. Therefore, part of 
the lactose was removed in the precipitation process. The 
content of lactose, which is a disaccharide, increases the 
solution’s osmolality.20,21 On the other hand, lactose enhanc-
es calcium absorption and promotes fermentation, which 
reduces intestinal constipation.22,23 The mean content of 
lactose in supplemented human milk was 9.2g/dL, in accor-
dance with the recommendation of 3 to 12g/dL. With the 
onset of minimal enteral feeding, the activity of lactase 
increases rapidly. Despite the increase in lactose content, 
osmolality was found to be 389.6mOsm/KgH2O. The osmo-
lality of food for premature infants should be less than 
450mOsm/kgH2O.
24 Santos,12 in 1997, fed VLBW infants 
human milk with added homologous supplement whose lac-
tose content was similar and reported good gastrointestinal 
tolerance. Thus, the lactose content found in this study 
seems to be adequate for feeding VLBW infants.
The amounts of proteins found in human milk with supple-
ment meet the AAP recommendation,25 in 1985, of 
2.9-3.3g/100kcal, and of the Canadian Society of Pediatrics,26 
which recommended 2.7-3.5g/kg/day in 1995. With a supply 
of supplemented milk of 150-200mL/kg a day, the intake of 
3.3-4.4g/kg of protein a day is attained, coincident with the 
interval of 3.5-4.0g/kg/day recommended by the European 
Society for Pediatric Gastroenterology, Hepatology, and 
Nutrition (ESPGHAN) in 2010.27
The sodium content found in supplemented milk also 
meets the recommendations of the AAP for infant formu-
las, which are 2.5-3.5mEq/kg/day, when 120kcal/kg/day 
are offered,25 and of ESPGHAN26 (2.7-4.6mEq/100kcal). If 
the child’s gastric capacity allows it, the intake of a vol-
ume of milk that supplies 4mEq/kg/day of sodium is rec-
ommended for the prevention of hyponatremia.25 As for 
potassium, supplemented human milk in this study had 
1.42mEq/dL of potassium. The estimated requirement of 
potassium can be supplied by breastfeeding, which con-
tains 1.25-1.60mEq/dL.28
The presence of calcium in human milk differs from that 
in infant formulas, not only in quantity, but also regarding 
the constituent chemical species due to differences in the 
protein fraction of human and cow’s milk. In formulas, cal-
cium is mainly associated with casein. In human milk, a 
high proportion of calcium constitutes part of the lipid 
fraction. In the aqueous fraction, most of the calcium is 
associated with whey proteins and low-molecular weight 
compounds. In human milk there is little calcium bound to 
casein. These differences in the chemical structure of the 
constituent species of the calcium content of milk explain 
the high bioavailability of calcium in human milk.28 Despite 
the significant increase in the levels of calcium and phos-
phorus in supplemented human milk compared to human 
milk without supplement, these levels do not meet the rec-
ommendations for very low birth weight infants, which, 
according to ESPGHAN, are 20-140mg/kg/day of calcium 
and 60-90mg/kg/day of phosphorus,27 and according to AAP, 
are 200 to 250mg/kg/day of calcium and 110 to 125mg/kg/
day of phosphorus.25 Still, this significant increase of 
approximately twice than that of human milk without sup-
plements is advantageous due to the increased bioavailabil-
ity of calcium and phosphorus in human milk when com-
pared to commercial supplements. Additionally, the acqui-
sition of calcium and phosphorus supplements alone is 
cheaper than purchasing multinutrient supplements. 
As the incorporation of fat in the fetus occurs in the last 
trimester, the VLBW infants are vulnerable to the lack of 
lipids. The fat in VLBW infants’ diet must meet the needs of 
fatty acids and prevent lack of calories.29 The amount of fat 
in the human milk with homologous supplement in g/100kcal 
was 4g, close to the recommendations of the AAP, 
4.5-6.0g/100kcal25 and of ESPGHAN,27 4.4-6.0g/100kcal. The 
contents of fat in human milk homologous supplement and 
of the human milk without supplement shown in the results 
Table 2 Mean nutritional content of homologous supplemented human milk (HM+HS) and human milk from a milk bank (HM).
Nutrient HM+HS HM Increase in folds p
Lactose (g/dL) 9.22 6.78 1.36 <0.001
Protein (g/dL) 2.20 1.13 1.95 <0.001
Lipids (g/dL) 2.91 1.49 1.95 <0.001
Energy (g/dL) 71.93 45.06 1.60 <0.001
Osmolality (mOsm/KgH2O) 389.6 267.70 1.45 <0.001
Sodium (mEq/dL) 2.04 0.9317 2.19 <0.001
Potassium (mEq/dL) 1.42 1.1817 1.20 <0.011
Calcium (mEq/dL) 43.44 24.7117 1.76 <0.001
Phosphorus (mEq/dL) 23.69 10.7517 2.20 <0.001
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are lower than the mean fat content in human milk described 
in the literature. This occurred because the milks used were 
not selected according to their caloric value, due to the 
difficulty of having surplus milk in the milk bank for research. 
Nevertheless, the supplement made with these “lean” milks 
was able to significantly improve the nutritional content of 
human milk from the bank for VLBW infants.
The milk produced by the mother of a preterm newborn 
has a different composition from mature milk, regarding 
protein and energy content and immunological constituents 
in the first weeks of production. These modifications make 
breast milk adapted to the needs of the premature infant. 
In the first four weeks, preterm human milk contains a 
higher concentration of nitrogen, protein with immune 
function, total lipids, medium-chain fatty acids, vitamins, 
calcium, sodium and energy than milk produced by mothers 
of full-term newborns. The greater the degree of prematu-
rity, the higher the lipid and protein content.1,30 With the 
exception of calcium and phosphorus, the nutrient levels 
evaluated in supplemented milk meet the recommenda-
tions for nutrition of VLBW infants and their composition is 
similar to preterm human milk, thus suitable for feeding 
these children. The result obtained in this study is similar 
to that of human milk with added supplements produced by 
Thomaz et al,14 and has a higher protein content than those 
produced by Santos12 and Valentini.13
The main limitations regarding the study methodology 
are its reproducibility, as the values of nutritional composi-
tion vary according to the human milk used; using different 
pools of human milk in the supplement production, dilution 
and comparison of their nutritional compositions, and the 
comparison of the mineral content with data from another 
study. Such limitations are justified below.
When reproducing the methodology used in this study, 
the results of the nutritional composition of human milk 
with or without supplement can vary according to the 
nutritional composition of the human milk used, which 
undergoes variations during the day, from one breast to 
another, from the beginning to the end of the feeding, and 
during the period of lactation. However, the main objective 
of this study is to show that the technique for supplement 
production is capable of making the milk from the milk 
bank more suitable for feeding VLBW infants without estab-
lishing selection and exclusion criteria for the milk, in addi-
tion to those that guarantee sanitary safety. This is due to 
the fact that, in human milk banks, there is usually no sur-
plus breast milk, and thus a technique that establishes 
selection criteria for the available milk used in the produc-
tion of the supplement would not be feasible. Because of 
this variation in availability of milk from the milk bank, in 
this study the milk used in the production of the supple-
ment, in the dilution and comparison of their nutritional 
compositions did not originate from the same pool, but 
represented mean values of different samples. 
A comparison of the mineral content of human milk with 
homologous supplement with human milk without supple-
ment was carried out with data published in another study, 
because the nutritional composition of human milk with no 
supplements is well described in the publications. 
Regarding the feasibility of the supplement production, 
the only initial cost to equip the milk bank and produce the 
homologous supplement is approximately U$19,000.00 (nine-
teen thousand American Dollars) to acquire the refrigerated 
centrifuge and the benchtop freeze-dryer. Considering that 
the market price of the commercial supplement box with 70 
vials is R$115.00, and one vial is enough to supplement 20mL 
of human milk, the cost to feed a child weighing 1.000g with 
a daily volume of 150mL/kg for 30 days will be approximate-
ly R$370.00. To feed 10 children a day with this volume for 1 
year, the cost will be R$44,400.00. Therefore, a neonatal 
unit that treats 10 children per month, using the proposed 
volume, will have spent in one year roughly the same amount 
needed to equip the human milk bank to produce the same 
homologous supplement.
The homologous supplement has advantages over com-
mercial ones, as it provides protein of high biological value 
and nutrients of human milk. The technique can be imple-
mented in human milk banks and has financial viability in 
developing countries, as it requires only an initial invest-
ment for the purchase of equipment and it reduces costs 
with commercial supplements.
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